Webinar on GE Trees and the U.S. Regulatory System
Thursday, March 8, 2018 at 2:00 pm Eastern Time
Watch the webinar recording below:
– Adam Costanza, Institute of Forest Biosciences – View Bio | View Slides
Adam Costanza is the president of the Institute of Forest Biosciences (IFB), a non-profit that fosters the use of science and technologies to create healthier and more productive forests now and for the future. The IFB supports responsible uses of advanced forest technologies that benefit society and the environment. Adam works with stakeholders to achieve these goals through policy development, technology creation, outreach, and education. Adam received his undergraduate degree through Chemical Engineering: Energy and the Environment from the University of Rochester. He went on to earn his Masters of Environmental Management degree from Duke University. During his 11-year tenure at IFB, he has helped develop international governance frameworks including the Greenhouse Gas Corporate Accounting Protocol and the Responsible Use: Biotech Tree Principles, is Co-Chair of the Tree Genes Initiative, manages biotechnology regulations for the Forest Health Initiative, and is a lead developer for open science systems that share information that improves the health and productivity of native and planted forests through the Forest.Health, TreeTaggr, Open Forestry, Pests by Zipcode, and Internet of Trees efforts. He has given numerous talks on the implications of using genetic modification on forest trees within national regulatory and global forest certification frameworks. His policy work includes regulatory framework whitepapers, lectures on public perception of the forest products industry at North Carolina State University, and an August 2015 article in the journal Science on regulation and certification of genetically engineered trees for forest health.
– Lori Knowles, University of Alberta and Institute of Forest Biosciences – View Bio | View Slides
Lori P. Knowles is an expert in international comparative law working as a consultant in Boston, USA, and as faculty at the University of Alberta, Canada, School of Public Health. She specializes in law, policy and ethics, particularly as it relates to emerging biotechnologies. Professor Knowles holds law degrees from Canada, the UK and the US, and has practiced and taught law in Canada and the US. She sits on the Government of Alberta’s Innovation and Research Council; is Past Chair of the Board of Directors of the Institute of Forest Biosciences; and is a special governmental employee for the US Food and Drug Administration. Professor Knowles has been a consultant to President Bush’s Council on Bioethics; President Clinton’s National Bioethics Advisory Commission; Genome Canada; the Canadian Biotechnology Advisory Committee; the Stem Cell Network of Canada; and the National Academy of Sciences, among others. She is the author of numerous publications, and lectures internationally on a wide range of law and medical-related topics, ranging from GMOs and synthetic biology, to stem cells and reproductive technology.
– William (Bill) Doley, USDA-APHIS-Biotechnology Regulatory Services – View Bio | View Slides
Dr. Bill Doley is a Government Relations Specialist in the Intergovernmental Operations Group of Biotechnology Regulatory Services (BRS) within the USDA’s Animal and Plant Health Inspection Service (APHIS). Bill started with BRS in 2010 as a Biotechnologist, and moved into his current role in 2013. Among other duties, he coordinates the Am I Regulated (AIR) process through which developers of genetically engineered (GE) organisms can inquire about the regulatory status of a described GE organism. Bill received a B.S. in plant science from Penn State, an M.S. in Plant Breeding and Genetics from the University of Minnesota, and a PhD in plant breeding from Michigan State University. Prior to joining USDA, Bill held positions with the American Crystal Sugar Company, American Cyanamid, BASF and the Danforth Center. Bill’s expertise includes plant breeding, herbicide tolerance, strategic relationships, project management and biotechnology product development.